Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation
about
Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular DiseaseSo! What's aging? Is cardiovascular aging a disease?Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effectsOpposing roles of FoxP1 and Nfat3 in transcriptional control of cardiomyocyte hypertrophyLow-dose ramipril treatment improves relaxation and calcium cycling after established cardiac hypertrophy.Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in ratsThe novel angiotensin II type 1 receptor (AT1R)-associated protein ATRAP downregulates AT1R and ameliorates cardiomyocyte hypertrophy.Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?Congestive heart failure arising from diastolic dysfunction in the presence of normal left-ventricular systolic function.Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction.The Renin-Angiotensin system mediates the effects of stretch on conduction velocity, connexin43 expression, and redistribution in intact ventricle.Localization of a small genomic region associated with elevated ACECharacterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression.Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme.The ACE gene and human performance: 12 years on.Hypertrophic stimuli induce transforming growth factor-beta 1 expression in rat ventricular myocytes.Fibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smooth muscle cells. Possible mediator of the response to vascular injury.Effects of angiotensin II generated by an angiotensin converting enzyme-independent pathway on left ventricular performance in the conscious baboonGlycolytic inhibition: effects on diastolic relaxation and intracellular calcium handling in hypertrophied rat ventricular myocytes.Increased angiotensin-I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction.Constitutively active calcineurin induces cardiac endoplasmic reticulum stress and protects against apoptosis that is mediated by alpha-crystallin-B.Pressure mediated hypertrophy and mechanical stretch up-regulate expression of the long form of leptin receptor (ob-Rb) in rat cardiac myocytes.Animal models of cardiovascular diseasesThe importance of early intervention in CHF--signs and symptom relief.Regulation of p53 by jagged1 contributes to angiotensin II-induced impairment of myocardial angiogenesis.Genetic models provide unique insight into angiotensin and bradykinin peptides in the extravascular compartment of the heart in vivo.The role of mAKAPβ in the process of cardiomyocyte hypertrophy induced by angiotensin IIIn vivo assessment of cardiac metabolism and function in the abdominal aortic banding model of compensated cardiac hypertrophyExacerbation of ischemic dysfunction by angiotensin II in red cell-perfused rabbit hearts. Effects on coronary flow, contractility, and high-energy phosphate metabolism.Alteration of growth responses in established cardiac pressure overload hypertrophy in rats with aortic bandingAngiotensin converting enzyme as a genetic risk factor for coronary artery spasm. Implication in the pathogenesis of myocardial infarction.The left ventricle in aortic stenosis: evidence for the use of ACE inhibitorsCytokine mRNA expression in postischemic/reperfused myocardium.Replacement of salt by a novel potassium- and magnesium-enriched salt alternative improves the cardiovascular effects of ramipril.MITF interacts with the SWI/SNF subunit, BRG1, to promote GATA4 expression in cardiac hypertrophy.Hepatocyte growth factor regulates angiotensin converting enzyme expressionAssociations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass.Reduction in left ventricular wall stress and improvement in function in failing hearts using Algisyl-LVR.Association of angiotensin converting enzyme and angiotensin II type 1 receptor genotypes with left ventricular function and mass in patients with angiographically normal coronary arteries.Local Application of Leptin Antagonist Attenuates Angiotensin II-Induced Ascending Aortic Aneurysm and Cardiac Remodeling.
P2860
Q28077454-67967B49-5FA4-4098-9E85-38549025CBBDQ28084852-6218238B-7F08-4C6C-B322-26E4F94B53C5Q28505671-0B50C394-59AC-43FB-9382-15B681A3DBF8Q28579882-E8614442-87E3-4511-9F67-9B1520C4158AQ31939851-B820098C-11CA-46A1-ACF9-5D3BEA3FA1FDQ33189269-537EF41C-021B-45EC-BFD1-2662D80FF125Q33289365-E4DB5684-2CD6-4C34-A76B-F9B3D45D4F87Q33586708-1F2409A0-82DF-4B84-A02B-C2F6A4BF3CC5Q33601844-880FC0ED-43BF-427C-BE67-4B1C88759620Q33899056-562F29FB-1F33-4FA8-B1CD-AFC2E7879EDBQ34117578-BDEBCC22-D705-46EA-81D5-E3D071EBAD78Q34146741-7E5167E0-B280-47C5-BC1E-9353562C2BB9Q34150245-CD6072F3-6A52-40FD-87DA-51D79CBB3D9EQ34182616-2051F3E6-2E67-45AB-B9AE-472639993C31Q34187481-255E3FD8-E647-4925-A35D-CCF1373C8624Q34189204-8E9256BA-E6AD-444D-9692-BEA2C82FC19CQ34196093-05718697-68CB-440F-B3B0-7E66C40C99F4Q34206697-AE82DCB7-8067-4A4E-98E5-CA3CE3757037Q34224023-5316FFE0-6A15-4FD2-B96A-3BF53E5B7D0EQ34235642-218025A8-7E29-4A24-89B8-041980D46993Q34276711-6D223282-B9E9-4F00-9F0F-D85671F3D487Q34523615-14816831-E6DC-497E-A1C0-E5E79912EB02Q34591282-1D52CA4B-3459-4F88-B811-1786A51FF9ACQ34610087-FDB388E4-81AB-42C2-B933-5FC5CEA60F88Q35009505-2043C745-57E4-4674-B1D1-6CE88A3A398DQ35125969-3AFA0E94-A674-4003-B62C-BC0D88D48A76Q35234255-FBFE4B02-721B-4DDB-8D4B-1FF9808AB833Q35449270-82D44CEF-8374-4C2A-8EEA-4BF3EB8A2942Q35597637-B7473784-E9F9-471D-8BBA-C16D487EB67AQ35768278-3ABE47A1-D5CD-4B4E-B7D7-540919C6EB19Q35769124-3AED894E-68EE-49A7-B9BA-EDB74AD44405Q35771487-0D257218-771B-4499-8A40-0CBD177660FDQ35796148-F018B4BE-8BD4-4CA7-B4B8-3E8D725B8C8FQ35874540-1D03D97F-D537-4247-A294-9089482F2160Q36269061-B96DD655-928F-46C0-90AD-98102A1D0479Q36740263-1D90D0C9-1EA0-40F3-BBE8-06B896FAF0A4Q36839438-DF58C870-3D88-438D-8313-F9081FE5ACD6Q36842148-F58DEB6C-60AF-43F2-8C62-5083D363A0BDQ36843948-F50DE269-9604-41E1-9415-0703814C297FQ36956817-A6EC5761-F945-4E4D-8956-DE57B9A6F48E
P2860
Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Increased rat cardiac angioten ...... contractility, and relaxation
@ast
Increased rat cardiac angioten ...... contractility, and relaxation
@en
type
label
Increased rat cardiac angioten ...... contractility, and relaxation
@ast
Increased rat cardiac angioten ...... contractility, and relaxation
@en
prefLabel
Increased rat cardiac angioten ...... contractility, and relaxation
@ast
Increased rat cardiac angioten ...... contractility, and relaxation
@en
P2093
P2860
P356
P1476
Increased rat cardiac angioten ...... contractility, and relaxation
@en
P2093
P2860
P304
P356
10.1172/JCI114924
P407
P577
1990-12-01T00:00:00Z